APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nivolumab Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nivolumab Drugs Industry Growth and Trends Forecast to 2032

2 January 202670 pages

Choose your research edition.

Industry ResearchNivolumab Drugs Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Nivolumab Drugs Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Nivolumab Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nivolumab Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Nivolumab Drugs Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Nivolumab Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nivolumab Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nivolumab Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nivolumab Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nivolumab Drugs include Bristol-Myers Squibb and Ono Pharmaceutical among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nivolumab Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nivolumab Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nivolumab Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nivolumab Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nivolumab Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nivolumab Drugs Market by Company

Bristol-Myers Squibb

Ono Pharmaceutical

Nivolumab Drugs Segment by Type

10ml

24ml

4ml

Nivolumab Drugs Segment by Application

Retail Pharmacy

Hospital Pharmacy

Other

Nivolumab Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nivolumab Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nivolumab Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nivolumab Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nivolumab Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nivolumab Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10ml Table 2. Major Company of 24ml Table 3. Major Company of 4ml Table 4. Global Nivolumab Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Nivolumab Drugs Sales by Type (2021-2026) & (K Units) Table 6. Global Nivolumab Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Nivolumab Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Nivolumab Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Nivolumab Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Nivolumab Drugs Sales by Type (2027-2032) & (K Units) Table 11. Global Nivolumab Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Nivolumab Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Nivolumab Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Nivolumab Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Nivolumab Drugs Sales by Type (2021-2026) & (K Units) Table 16. North America Nivolumab Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Nivolumab Drugs Sales by Type (2021-2026) & (K Units) Table 18. Europe Nivolumab Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Nivolumab Drugs Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Nivolumab Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Nivolumab Drugs Sales by Type (2021-2026) & (K Units) Table 22. Latin America Nivolumab Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Nivolumab Drugs Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Nivolumab Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Nivolumab Drugs Industry Trends Table 26. Nivolumab Drugs Industry Drivers Table 27. Nivolumab Drugs Industry Opportunities and Challenges Table 28. Nivolumab Drugs Industry Restraints Table 29. Global Nivolumab Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Nivolumab Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Nivolumab Drugs Sales by Company (2021-2026) & (K Units) Table 32. Global Nivolumab Drugs Sales Share by Company (2021-2026) Table 33. Global Nivolumab Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Nivolumab Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Nivolumab Drugs Major Company Production Sites and Headquarters Table 36. Global Nivolumab Drugs Company, Product Type & Application Table 37. Global Nivolumab Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Nivolumab Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Nivolumab Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Nivolumab Drugs Sales by Region (2021-2026) & (K Units) Table 42. Global Nivolumab Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Nivolumab Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Nivolumab Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Nivolumab Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Nivolumab Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Nivolumab Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Nivolumab Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Nivolumab Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Nivolumab Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Nivolumab Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Nivolumab Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Nivolumab Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Nivolumab Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Nivolumab Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Nivolumab Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Nivolumab Drugs Sales by Application (2027-2032) & (K Units) Table 58. Global Nivolumab Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Nivolumab Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Nivolumab Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Nivolumab Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Nivolumab Drugs Sales by Application (2021-2026) & (K Units) Table 63. North America Nivolumab Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Nivolumab Drugs Sales by Application (2021-2026) & (K Units) Table 65. Europe Nivolumab Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Nivolumab Drugs Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Nivolumab Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Nivolumab Drugs Sales by Application (2021-2026) & (K Units) Table 69. Latin America Nivolumab Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Nivolumab Drugs Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Nivolumab Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Bristol-Myers Squibb Company Information Table 73. Bristol-Myers Squibb Business Overview Table 74. Bristol-Myers Squibb Nivolumab Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Bristol-Myers Squibb Nivolumab Drugs Product Portfolio Table 76. Bristol-Myers Squibb Recent Development Table 77. Ono Pharmaceutical Company Information Table 78. Ono Pharmaceutical Business Overview Table 79. Ono Pharmaceutical Nivolumab Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Ono Pharmaceutical Nivolumab Drugs Product Portfolio Table 81. Ono Pharmaceutical Recent Development Table 82. North America Nivolumab Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 83. North America Nivolumab Drugs Sales by Country (2021-2026) & (K Units) Table 84. North America Nivolumab Drugs Sales Market Share by Country (2021-2026) Table 85. North America Nivolumab Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 86. North America Nivolumab Drugs Sales Market Share Forecast by Country (2027-2032) Table 87. North America Nivolumab Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 88. North America Nivolumab Drugs Market Size by Country (2021-2026) & (US$ Million) Table 89. North America Nivolumab Drugs Market Share by Country (2021-2026) Table 90. North America Nivolumab Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 91. North America Nivolumab Drugs Market Share Forecast by Country (2027-2032) Table 92. Europe Nivolumab Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 93. Europe Nivolumab Drugs Sales by Country (2021-2026) & (K Units) Table 94. Europe Nivolumab Drugs Sales Market Share by Country (2021-2026) Table 95. Europe Nivolumab Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 96. Europe Nivolumab Drugs Sales Market Share Forecast by Country (2027-2032) Table 97. Europe Nivolumab Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 98. Europe Nivolumab Drugs Market Size by Country (2021-2026) & (US$ Million) Table 99. Europe Nivolumab Drugs Market Share by Country (2021-2026) Table 100. Europe Nivolumab Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 101. Europe Nivolumab Drugs Market Share Forecast by Country (2027-2032) Table 102. Asia-Pacific Nivolumab Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. Asia-Pacific Nivolumab Drugs Sales by Country (2021-2026) & (K Units) Table 104. Asia-Pacific Nivolumab Drugs Sales Market Share by Country (2021-2026) Table 105. Asia-Pacific Nivolumab Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 106. Asia-Pacific Nivolumab Drugs Sales Market Share Forecast by Country (2027-2032) Table 107. Asia-Pacific Nivolumab Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. Asia-Pacific Nivolumab Drugs Market Size by Country (2021-2026) & (US$ Million) Table 109. Asia-Pacific Nivolumab Drugs Market Share by Country (2021-2026) Table 110. Asia-Pacific Nivolumab Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. Asia-Pacific Nivolumab Drugs Market Share Forecast by Country (2027-2032) Table 112. Latin America Nivolumab Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Latin America Nivolumab Drugs Sales by Country (2021-2026) & (K Units) Table 114. Latin America Nivolumab Drugs Sales Market Share by Country (2021-2026) Table 115. Latin America Nivolumab Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 116. Latin America Nivolumab Drugs Sales Market Share Forecast by Country (2027-2032) Table 117. Latin America Nivolumab Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Latin America Nivolumab Drugs Market Size by Country (2021-2026) & (US$ Million) Table 119. Latin America Nivolumab Drugs Market Share by Country (2021-2026) Table 120. Latin America Nivolumab Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Latin America Nivolumab Drugs Market Share Forecast by Country (2027-2032) Table 122. Middle East and Africa Nivolumab Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Middle East and Africa Nivolumab Drugs Sales by Country (2021-2026) & (K Units) Table 124. Middle East and Africa Nivolumab Drugs Sales Market Share by Country (2021-2026) Table 125. Middle East and Africa Nivolumab Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 126. Middle East and Africa Nivolumab Drugs Sales Market Share Forecast by Country (2027-2032) Table 127. Middle East and Africa Nivolumab Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Middle East and Africa Nivolumab Drugs Market Size by Country (2021-2026) & (US$ Million) Table 129. Middle East and Africa Nivolumab Drugs Market Share by Country (2021-2026) Table 130. Middle East and Africa Nivolumab Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Middle East and Africa Nivolumab Drugs Market Share Forecast by Country (2027-2032) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Nivolumab Drugs Distributors List Table 135. Nivolumab Drugs Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Nivolumab Drugs Image Figure 2. Global Nivolumab Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nivolumab Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Nivolumab Drugs Sales (2021-2032) & (K Units) Figure 5. 10ml Image Figure 6. Global 10ml Sales YoY Growth (2021-2032) & (K Units) Figure 7. 24ml Image Figure 8. Global 24ml Sales YoY Growth (2021-2032) & (K Units) Figure 9. 4ml Image Figure 10. Global 4ml Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Nivolumab Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Nivolumab Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Nivolumab Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Nivolumab Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Nivolumab Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Nivolumab Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Nivolumab Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Nivolumab Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Nivolumab Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Nivolumab Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Nivolumab Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Nivolumab Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Nivolumab Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Retail Pharmacy Image Figure 26. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Hospital Pharmacy Image Figure 28. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Nivolumab Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Nivolumab Drugs Market Share by Application 2025 VS 2032 Figure 33. North America Nivolumab Drugs Sales Market Share in Volume by Application in 2025 Figure 34. North America Nivolumab Drugs Sales Market Share in Value by Application in 2025 Figure 35. Europe Nivolumab Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Europe Nivolumab Drugs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Nivolumab Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Nivolumab Drugs Sales Market Share in Value by Application in 2025 Figure 39. Latin America Nivolumab Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Nivolumab Drugs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Nivolumab Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Nivolumab Drugs Sales Market Share in Value by Application in 2025 Figure 43. North America Nivolumab Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Nivolumab Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Nivolumab Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Nivolumab Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Nivolumab Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Nivolumab Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Nivolumab Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Nivolumab Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Nivolumab Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Nivolumab Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Nivolumab Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Nivolumab Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Nivolumab Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Nivolumab Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Nivolumab Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Nivolumab Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Nivolumab Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Nivolumab Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Nivolumab Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Nivolumab Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Nivolumab Drugs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Nivolumab Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 10ml
  • 24ml
  • 4ml
Applications
  • Retail Pharmacy
  • Hospital Pharmacy
  • Other
Companies covered
  • Bristol-Myers Squibb
  • Ono Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nivolumab Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nivolumab Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nivolumab Drugs Market by Type
  6. 1.3.1 10ml
  7. 1.3.2 24ml
  8. 1.3.3 4ml
  9. 1.4 Global Nivolumab Drugs Market Size by Type
  10. 1.4.1 Global Nivolumab Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Nivolumab Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Nivolumab Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Nivolumab Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Nivolumab Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Nivolumab Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Nivolumab Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Nivolumab Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nivolumab Drugs Industry Trends
  2. 2.2 Nivolumab Drugs Industry Drivers
  3. 2.3 Nivolumab Drugs Industry Opportunities and Challenges
  4. 2.4 Nivolumab Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nivolumab Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Nivolumab Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Nivolumab Drugs Price (2021-2026)
  4. 3.4 Global Nivolumab Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nivolumab Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Nivolumab Drugs Company, Product Type & Application
  7. 3.7 Global Nivolumab Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nivolumab Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nivolumab Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nivolumab Drugs Tier 1, Tier 2, and Tier 3
4 Nivolumab Drugs Regional Status and Outlook
  1. 4.1 Global Nivolumab Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nivolumab Drugs Historic Market Size by Region
  3. 4.2.1 Global Nivolumab Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nivolumab Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nivolumab Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nivolumab Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Nivolumab Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nivolumab Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nivolumab Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nivolumab Drugs by Application
  1. 5.1 Nivolumab Drugs Market by Application
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Hospital Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Nivolumab Drugs Market Size by Application
  6. 5.2.1 Global Nivolumab Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Nivolumab Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Nivolumab Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Nivolumab Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Nivolumab Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Nivolumab Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Nivolumab Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Nivolumab Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bristol-Myers Squibb
  2. 6.1.1 Bristol-Myers Squibb Company Information
  3. 6.1.2 Bristol-Myers Squibb Business Overview
  4. 6.1.3 Bristol-Myers Squibb Nivolumab Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bristol-Myers Squibb Nivolumab Drugs Product Portfolio
  6. 6.1.5 Bristol-Myers Squibb Recent Developments
  7. 6.2 Ono Pharmaceutical
  8. 6.2.1 Ono Pharmaceutical Company Information
  9. 6.2.2 Ono Pharmaceutical Business Overview
  10. 6.2.3 Ono Pharmaceutical Nivolumab Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Ono Pharmaceutical Nivolumab Drugs Product Portfolio
  12. 6.2.5 Ono Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Nivolumab Drugs Sales by Country
  2. 7.1.1 North America Nivolumab Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nivolumab Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Nivolumab Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nivolumab Drugs Market Size by Country
  6. 7.2.1 North America Nivolumab Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nivolumab Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Nivolumab Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nivolumab Drugs Sales by Country
  2. 8.1.1 Europe Nivolumab Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nivolumab Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Nivolumab Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nivolumab Drugs Market Size by Country
  6. 8.2.1 Europe Nivolumab Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nivolumab Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nivolumab Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nivolumab Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Nivolumab Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nivolumab Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nivolumab Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nivolumab Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Nivolumab Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nivolumab Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nivolumab Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nivolumab Drugs Sales by Country
  2. 10.1.1 South America Nivolumab Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nivolumab Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Nivolumab Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nivolumab Drugs Market Size by Country
  6. 10.2.1 South America Nivolumab Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nivolumab Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Nivolumab Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nivolumab Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Nivolumab Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nivolumab Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nivolumab Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nivolumab Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Nivolumab Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nivolumab Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nivolumab Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nivolumab Drugs Value Chain Analysis
  2. 12.1.1 Nivolumab Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nivolumab Drugs Production Mode & Process
  7. 12.2 Nivolumab Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nivolumab Drugs Distributors
  10. 12.2.3 Nivolumab Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst